Samar K. Kassim

2.3k total citations
37 papers, 584 citations indexed

About

Samar K. Kassim is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Samar K. Kassim has authored 37 papers receiving a total of 584 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Oncology. Recurrent topics in Samar K. Kassim's work include Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (4 papers) and Epigenetics and DNA Methylation (4 papers). Samar K. Kassim is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Hepatitis B Virus Studies (4 papers) and Epigenetics and DNA Methylation (4 papers). Samar K. Kassim collaborates with scholars based in Egypt, United States and Tunisia. Samar K. Kassim's co-authors include Ali Khalifa, Salah T. Fayed, Sanaa Eissa, O. El-Ahmady, Sawsan Aboul‐Fotouh, Md. Imtaiyaz Hassan, Aboul Ella Hassanien, Maha Sallam, Hesham A. Hefny and Ahmed M. Abdel-Tawab and has published in prestigious journals such as Cancer, The American Journal of Gastroenterology and Gene.

In The Last Decade

Samar K. Kassim

37 papers receiving 570 citations

Peers

Samar K. Kassim
Samar K. Kassim
Citations per year, relative to Samar K. Kassim Samar K. Kassim (= 1×) peers Lijing Zhu

Countries citing papers authored by Samar K. Kassim

Since Specialization
Citations

This map shows the geographic impact of Samar K. Kassim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samar K. Kassim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samar K. Kassim more than expected).

Fields of papers citing papers by Samar K. Kassim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samar K. Kassim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samar K. Kassim. The network helps show where Samar K. Kassim may publish in the future.

Co-authorship network of co-authors of Samar K. Kassim

This figure shows the co-authorship network connecting the top 25 collaborators of Samar K. Kassim. A scholar is included among the top collaborators of Samar K. Kassim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samar K. Kassim. Samar K. Kassim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jongeneel, C. Victor, Maritha J. Kotze, Archana Bhaw‐Luximon, et al.. (2022). A View on Genomic Medicine Activities in Africa: Implications for Policy. Frontiers in Genetics. 13. 769919–769919. 18 indexed citations
2.
Kassim, Samar K., et al.. (2021). The effect of nutri-epigenomic agent “pterostilbene” on the expression of ADAR enzyme(s) in HCC animal model. QJM. 114(Supplement_1). 2 indexed citations
5.
Khairy, Eman, et al.. (2018). Evaluation of leptin and MMP2 genes methylation in childhood obesity. Gene Reports. 11. 79–86. 4 indexed citations
7.
Kamal, Sanaa M., et al.. (2015). The accuracy and cost‐effectiveness of hepatitis C core antigen assay in the monitoring of anti‐viral therapy in patients with chronic hepatitis C genotype 4. Alimentary Pharmacology & Therapeutics. 42(3). 307–318. 20 indexed citations
8.
Aboul‐Fotouh, Sawsan, et al.. (2014). Lipopolysaccharide repeated challenge followed by chronic mild stress protocol introduces a combined model of depression in rats: Reversibility by imipramine and pentoxifylline. Pharmacology Biochemistry and Behavior. 126. 152–162. 49 indexed citations
9.
Louka, Manal L., et al.. (2014). Validation of analytical breast cancer microarray analysis in medical laboratory. Medical Oncology. 31(10). 201–201. 3 indexed citations
10.
Hassan, Md. Imtaiyaz, et al.. (2007). Antiproliferative effect of hepatitis C virus on mitogen-stimulated peripheral blood mononuclear cells: Potential role in viral persistence in Egyptian patients. Clinical Biochemistry. 40(16-17). 1173–1179. 2 indexed citations
11.
Eissa, Sanaa, et al.. (2005). Detection of bladder carcinoma by combined testing of urine for hyaluronidase and cytokeratin 20 RNAs. Cancer. 103(7). 1356–1362. 50 indexed citations
12.
Kassim, Samar K., et al.. (2004). Vascular endothelial growth factor and interleukin-8 are associated with poor prognosis in epithelial ovarian cancer patients. Clinical Biochemistry. 37(5). 363–369. 118 indexed citations
13.
Kassim, Samar K., et al.. (2002). The role of interleukin-12, and tissue antioxidants in chronic sinusitis. Clinical Biochemistry. 35(5). 369–375. 13 indexed citations
15.
Kassim, Samar K., et al.. (2002). Serum nitrates and vasoactive intestinal peptide in patients with gastroesophageal reflux disease. Clinical Biochemistry. 35(8). 641–646. 11 indexed citations
16.
Kassim, Samar K., et al.. (2001). Telomerase activity, and tissue polypeptide specific antigen (TPS) in Egyptian breast cancer patients. Clinical Biochemistry. 34(6). 499–504. 8 indexed citations
17.
Kassim, Samar K., et al.. (1999). Increased bcl-2 expression is associated with primary resistance to chemotherapy in human epithelial ovarian cancer. Clinical Biochemistry. 32(5). 333–338. 35 indexed citations
18.
Hassan, Md. Imtaiyaz, et al.. (1999). Cis-platinum–induced immunosuppression: relationship to melatonin in human peripheral blood mononuclear cells. Clinical Biochemistry. 32(8). 621–626. 17 indexed citations
19.
Fayed, Salah T., et al.. (1998). The Value of CA 125 and CA72‐4 in Management of Patients with Epithelial Ovarian Cancer. Disease Markers. 14(3). 155–160. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026